FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market

March 2006

FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market.

FDA advisors now say that OTC epinephrine inhalers DON'T offer an important health benefit...and SHOULDN'T be exempt from the ban on chlorofluorocarbon (CFC) propellants.

Wyeth is trying to reformulate Primatene Mist. But it could take 5 years for the new version to be tested and approved.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

proliferation of drugs with black box warnings and required MedGuides
Cardiology Ranexa (ranolazine) for chronic angina
Cardiology LOW-dose vitamin K supplements to stabilize the effect of warfarin in certain patients
Osteoporosis IV form of Boniva (ibandronate)
whether saw palmetto is effective for benign prostatic hyperplasia (BPH)
American Heart Association now says NOT to rely on soy protein or isoflavone supplements to prevent heart disease
Diabetes whether sulfonylureas increase mortality
Diabetes Many patients are looking forward to trying the new inhaled insulin, Exubera
Diabetes Apidra (insulin glulisine) is the newest rapid-acting insulin
Statins how to monitor for myopathy in patients taking statins
FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market
Kidney Disease Even patients with SEVERE kidney disease seem to benefit from ACE inhibitors
Obesity & Weight Loss Acomplia and OTC orlistat for weight loss
Infectious Diseases possible liver toxicity in patients taking Ketek (telithromycin)
Infectious Diseases Tequin (gatifloxacin) is now contraindicated for diabetes patients

FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents